AU2002223058A1 - Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling - Google Patents
Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peelingInfo
- Publication number
- AU2002223058A1 AU2002223058A1 AU2002223058A AU2305802A AU2002223058A1 AU 2002223058 A1 AU2002223058 A1 AU 2002223058A1 AU 2002223058 A AU2002223058 A AU 2002223058A AU 2305802 A AU2305802 A AU 2305802A AU 2002223058 A1 AU2002223058 A1 AU 2002223058A1
- Authority
- AU
- Australia
- Prior art keywords
- oxothiazolidine
- carboxylic acid
- acid derivatives
- promoting skin
- skin peeling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
2-oxothiazolidine-4-carboxylic acid compounds having the structural formula (I): are suited for promoting desquamation of the skin and/or stimulating epidermal renewal and/or combating aging of the skin.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0014865 | 2000-11-17 | ||
FR0014865A FR2816838B1 (en) | 2000-11-17 | 2000-11-17 | USE OF DERIVATIVES OF 2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID AS PRODESQUAMANTS |
PCT/FR2001/003523 WO2002039976A1 (en) | 2000-11-17 | 2001-11-12 | Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002223058A1 true AU2002223058A1 (en) | 2002-05-27 |
Family
ID=8856595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002223058A Abandoned AU2002223058A1 (en) | 2000-11-17 | 2001-11-12 | Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling |
Country Status (9)
Country | Link |
---|---|
US (3) | US20040006115A1 (en) |
EP (1) | EP1337234B1 (en) |
JP (1) | JP4072433B2 (en) |
AT (1) | ATE495736T1 (en) |
AU (1) | AU2002223058A1 (en) |
DE (1) | DE60143906D1 (en) |
ES (1) | ES2360204T3 (en) |
FR (1) | FR2816838B1 (en) |
WO (1) | WO2002039976A1 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040161392A1 (en) * | 2003-02-19 | 2004-08-19 | L'oreal S.A. | Skin peeling composition and method |
FR2888494B1 (en) * | 2005-07-13 | 2014-03-14 | Oreal | USE OF UREA COMPOUNDS TO PROMOTE DESQUACATION |
SG170767A1 (en) * | 2005-12-23 | 2011-05-30 | Zealand Pharma As | Modified lysine-mimetic compounds |
AR064626A1 (en) * | 2006-12-21 | 2009-04-15 | Wyeth Corp | SYNTHESIS OF PIRROLIDINE COMPOUNDS |
FR2921257B1 (en) | 2007-09-21 | 2009-11-06 | Exsymol Sa | TOPICAL USE OF THIAZOLIDINE DERIVATIVES FROM THE CONSEQUENCES OF OXIDATIVE SKIN STRESS |
ES2336995B1 (en) | 2008-10-13 | 2011-02-09 | Lipotec, S.A. | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION FOR SKIN CARE, HAIR LEATHER AND NAILS. |
CN102917685B (en) | 2010-05-28 | 2015-11-25 | 味之素株式会社 | Cysteine derivative |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT2782584T (en) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Natural combination hormone replacement formulations and therapies |
JP5994789B2 (en) * | 2011-11-30 | 2016-09-21 | 味の素株式会社 | Anti-wrinkle cosmetic |
WO2013081193A1 (en) * | 2011-11-30 | 2013-06-06 | 味の素株式会社 | Cosmetic containing cysteine derivative and alcohol |
WO2013081147A1 (en) * | 2011-11-30 | 2013-06-06 | 味の素株式会社 | Whitening cosmetic |
WO2013081192A1 (en) * | 2011-11-30 | 2013-06-06 | 味の素株式会社 | Cosmetic containing cysteine derivative and surfactant |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
WO2014203176A1 (en) * | 2013-06-19 | 2014-12-24 | Kop Research Centre Pvt Ltd | Water soluble compositions for treating hair loss & promoting hair growth |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
KR20180126582A (en) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
JP6989864B2 (en) | 2017-05-05 | 2022-02-03 | ジーランド ファーマ,アー/エス | Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease |
US20200383891A1 (en) * | 2017-12-20 | 2020-12-10 | Conopco, Inc., D/B/A Unilever | Deodorant compositions |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4806525A (en) * | 1987-06-18 | 1989-02-21 | Mavi S.R.L. | Formulation comprising gelatin and glycine for treating the dryness of skin |
US5208249A (en) * | 1992-08-20 | 1993-05-04 | Clintec Nutrition Co. | Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate |
AU7596994A (en) * | 1993-11-01 | 1995-05-18 | Free Radical Sciences, Inc. | Methods and compositions for retarding the aging process |
US5681852A (en) * | 1993-11-12 | 1997-10-28 | The Procter & Gamble Company | Desquamation compositions |
DE4444238A1 (en) * | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Cosmetic or dermatological drug combinations of cinnamic acid derivatives and flavone glycosides |
KR100294382B1 (en) * | 1995-05-26 | 2001-10-19 | 알 브이 테이트 (로드니 비버스 테이트), 에이치 드로이. 씨. 지. 오닌크, 이. 에디, 산드라 웨드워즈 (에스 제이 에드워즈) | Treatment Regime for Skin |
FR2742750B1 (en) * | 1995-12-22 | 1998-01-30 | Oreal | NOVEL DERIVATIVES OF L-2-OXOTHIAZOLIDINE 4-CARBOXYLIC ACID AND THEIR USE FOR SKIN CARE |
FR2742658B1 (en) * | 1995-12-22 | 1998-01-30 | Oreal | USE OF PROCYSTEIN AS A DEPIGMENTING AGENT |
US6063389A (en) * | 1995-12-22 | 2000-05-16 | L'oreal | Composition for depigmenting or bleaching mammalian skin containing L-2-oxothiazolidine-4-carboxylic acid and a polyol |
FR2751331A1 (en) * | 1996-07-18 | 1998-01-23 | Oreal | NOVEL KOJIC ACID DERIVATIVE AND ITS USE AS DEPIGMENTING AGENT |
DE852949T1 (en) * | 1997-03-31 | 1998-11-19 | Shiseido Co Ltd | Use of alpha-amino acids to promote desmosomal degradation or desquamation of the horny layer |
FR2767833B1 (en) * | 1997-08-29 | 2001-03-02 | Oreal | ISOLATED SKIN POLYPEPTIDE AND ITS USE |
FR2773323B1 (en) * | 1998-01-05 | 2000-02-11 | Oreal | COMPOSITION CONTAINING A COMBINATION OF PROCYSTEIN AND POLYOL |
US5989527A (en) * | 1998-01-26 | 1999-11-23 | Inolex Investment Corporation | Compositions and methods for improving the performance of chemical exfoliating agents, sunless tanning agents, skin lightening agents and insect repellents |
FR2790953B1 (en) * | 1999-03-19 | 2002-08-09 | Oreal | CONTINUOUS AQUEOUS PHASE COMPOSITION CONTAINING L-2-OXOTHIAZOLIDINE 4-CARBOXYLIC ACID |
-
2000
- 2000-11-17 FR FR0014865A patent/FR2816838B1/en not_active Expired - Lifetime
-
2001
- 2001-11-12 DE DE60143906T patent/DE60143906D1/en not_active Expired - Lifetime
- 2001-11-12 AT AT01996360T patent/ATE495736T1/en not_active IP Right Cessation
- 2001-11-12 ES ES01996360T patent/ES2360204T3/en not_active Expired - Lifetime
- 2001-11-12 WO PCT/FR2001/003523 patent/WO2002039976A1/en active Application Filing
- 2001-11-12 JP JP2002542351A patent/JP4072433B2/en not_active Expired - Fee Related
- 2001-11-12 AU AU2002223058A patent/AU2002223058A1/en not_active Abandoned
- 2001-11-12 EP EP01996360A patent/EP1337234B1/en not_active Expired - Lifetime
-
2003
- 2003-05-19 US US10/440,316 patent/US20040006115A1/en not_active Abandoned
-
2007
- 2007-05-30 US US11/806,218 patent/US20070232574A1/en not_active Abandoned
-
2010
- 2010-01-06 US US12/683,088 patent/US20100179200A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2004517063A (en) | 2004-06-10 |
ES2360204T3 (en) | 2011-06-01 |
US20040006115A1 (en) | 2004-01-08 |
ATE495736T1 (en) | 2011-02-15 |
EP1337234A1 (en) | 2003-08-27 |
FR2816838A1 (en) | 2002-05-24 |
EP1337234B1 (en) | 2011-01-19 |
WO2002039976A1 (en) | 2002-05-23 |
JP4072433B2 (en) | 2008-04-09 |
US20100179200A1 (en) | 2010-07-15 |
FR2816838B1 (en) | 2004-12-03 |
US20070232574A1 (en) | 2007-10-04 |
DE60143906D1 (en) | 2011-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002223058A1 (en) | Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling | |
PL341364A1 (en) | 4-hydroxyqinoline-3-carboxamides and hydrazides as antiviral agents | |
AU2795000A (en) | Epothilone derivatives and their use as antitumor agents | |
NO20054476L (en) | Compounds for the treatment of pain | |
AU3804500A (en) | 2-amino-6-anilino-purines and their use as medicaments | |
AP2001002224A0 (en) | Benzoheterocycles and their use as MEK inhibitors. | |
GB9801690D0 (en) | Therapeutic agents | |
AU2002246728A1 (en) | Carboline derivatives | |
AU2002352443A1 (en) | Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3 | |
AU2002213421A1 (en) | Condensed pyridoindole derivatives | |
AU2002249890A1 (en) | Carboline derivatives | |
AU2001247968A1 (en) | Use of asiatic acid or asiaticoside for treatment of cancer | |
WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
MXPA04004372A (en) | Heterocyclic derivatives of glycinamide and their medical use. | |
MY133785A (en) | Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias | |
WO2004024064A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
IL150125A0 (en) | Novel compounds | |
AU2001291725A1 (en) | Heterocyclic mutilin esters and their use as antibacterials | |
AU2001263278A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
AP2001002274A0 (en) | Rescorcinol derivatives. | |
AU2002302685A1 (en) | Use of compounds modulating rxr-ppar heterodimer activity as medicine for treating hepatitis c | |
AU5630399A (en) | Use of at least a10-hydroxy-2- decenoic acid derivative in composition for promoting skin scaling | |
AU2002212489A1 (en) | Veterinary composition for the topical treatment of traumatized or inflamed skin | |
AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
AU2003250001A1 (en) | Use of compositions comprising benzoyl peroxide and glycyrrhetinic acid for the treatment of acne |